Skip to main content
Equibles

BARCLAYS PLC

Position in LSTA — Lisata Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to LSTA Full portfolio

Position in LSTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$238
+$228 QoQ
Shares Held
70
+1650.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 31 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. LSTA ranks #411 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in LSTA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $238 70
2025-09-30 $10 4
2025-06-30 $11 4
2025-03-31 $9 4
2024-12-31 $11 4
2024-09-30 $21 7
2024-06-30 $13 4
2024-03-31 $12 4
2023-12-31 $10 4
2023-09-30 $8 4
2023-06-30 $99 27
2023-03-31 $19 6
2022-12-31 $10 4
2022-09-30 $18 4